Monthly Archives: July 2014
Accident Attorneys in Columbia Applaud the New Law As of June 2014, the Palmetto State proudly joins 48 others in banning texting while driving. The ban supersedes at least 19 contradictory city and county ordinances on texting while driving, finally achieving consistent standards for the entire state. The new law reads as follows in pertinent part: It is unlawful for a person to use a wireless electronic communication device to compose, send, or read a text-based communication while operating a motor vehicle on the public streets and highways of this State. This ban on texting while driving is necessary for South Carolina. The State Department of Public Safety reported that during a single two-year period, the combined number of distracted driving accidents in just one tri-county area was over 10,000. Of these, almost a third resulted in injury and 20 were fatal. Is the Texting While Driving Ban Strict Enough?…
Read More »
A Greenville man is facing 10 years in prison for causing a hit-and-run crash that killed one passenger and injured three others. In July 2013, two married couples were returning from a music event, Fridays by the Fountain, when their golf cart was rear-ended by a burgundy Pontiac. The driver fled the scene, but the police arrested him the following morning. A 75-year-old woman visiting from Tennessee died at the scene after suffering blunt force trauma to the head, neck and chest. The other three riders were taken to Greenville Memorial Hospital for treatment and were listed in fair to serious condition. The reckless driver was charged with three counts of a hit and run resulting in injury and one charge of a hit and run resulting in death. He has been sentenced to 10 years for each offense, set to run concurrently. Drivers flee the scene for a number…
Read More »
Sun Pharmaceutical Industries Ltd, an India-based drug manufacturer, is voluntarily recalling more than 40,000 bottles of a common antidepressant after it failed to meet dissolution standards. Venlafaxine hydrochloride, more commonly known as Effexor, is used to treat adults suffering from major depressive disorder, social phobias and general anxiety and panic disorders. Like most antidepressants, Effexor works by increasing concentrations of serotonin and norepinephrine in the brain. When a drug undergoes performance testing, dissolution standards help inspectors determine how effective it will be in the body. Drugs that fail dissolution tests could dissolve too slowly to be effective, or too quickly, overwhelming the patient’s system. Sun Pharmaceutical voluntarily issued the recall in June. The Food and Drug Administration (FDA) classified the preventative measure as a Class II recall, meaning that the drug’s defects could cause temporary or medically reversible health problems. The Indian drug manufacturer has suffered several setbacks this year….
Read More »